Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 6
Submit an article Journal homepage
365
Views
23
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Azotemia associated with use of lenalidomide in plasma cell dyscrasias

Eric D. Batts University Hospitals Case Medical Center and the Ireland Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH, USA
,
Vaishali Sanchorawala Section of Hematology/Oncology, Department of Medicine, Boston University Medical Center, Boston, MA, USA
,
Yael Hegerfeldt University Hospitals Case Medical Center and the Ireland Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH, USA
&
Hillard M. Lazarus University Hospitals Case Medical Center and the Ireland Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH, USACorrespondence[email protected]
, MD, FACP
Pages 1108-1115 | Received 22 Oct 2007, Accepted 27 Feb 2008, Published online: 01 Jul 2009

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Alex Dinh, Matthew B. Palmer, Jakub Svoboda & Jonathan J. Hogan. (2019) Lenalidomide-induced tubulointerstitial nephritis in Hodgkin lymphoma. Leukemia & Lymphoma 60:12, pages 3084-3086.
Read now
Mahmoud R Gaballa, Jacob P Laubach, Robert L Schlossman, Katherine Redman, Kimberly Noonan, Constantine S Mitsiades, Irene M Ghobrial, Nikhil Munshi, Kenneth C Anderson & Paul G Richardson. (2012) Management of myeloma-associated renal dysfunction in the era of novel therapies. Expert Review of Hematology 5:1, pages 51-68.
Read now
Pasquale Niscola, Gisella Vischini, Andrea Tendas, Laura Scaramucci, Marco Giovannini, Francesco Bondanini, Claudio Romani, Gregorio Antonio Brunetti, Claudio Cartoni, Luca Cupelli, Michele Ferrannini, Alessio Perrotti, Giovanni Del Poeta, Roberto Palumbo & Paolo de Fabritiis. (2011) Management of hematological malignancies in patients affected by renal failure. Expert Review of Anticancer Therapy 11:3, pages 415-432.
Read now
Jacob P Laubach, Robert L Schlossman, Constantine S Mitsiades, Kenneth C Anderson & Paul G Richardson. (2011) Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma. Expert Review of Hematology 4:1, pages 51-60.
Read now

Articles from other publishers (19)

Satoru Muto, Takeshi Matsubara, Takamitsu Inoue, Hiroshi Kitamura, Kazuhiro Yamamoto, Taisuke Ishii, Masahiko Yazawa, Ryohei Yamamoto, Naoto Okada, Kiyoshi Mori, Hiroyuki Yamada, Takashige Kuwabara, Atsushi Yonezawa, Takuya Fujimaru, Haruna Kawano, Hideki Yokoi, Kent Doi, Junichi Hoshino & Motoko Yanagita. (2023) Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022. International Journal of Clinical Oncology.
Crossref
Friederike Bachmann, Martin Schreder, Monika Engelhardt, Christian Langer, Denise Wolleschak, Lars Olof Mügge, Heinz Dürk, Kerstin Schäfer-Eckart, Igor Wolfgang Blau, Martin Gramatzki, Peter Liebisch, Matthias Grube, Ivana v Metzler, Florian Bassermann, Bernd Metzner, Christoph Röllig, Bernd Hertenstein, Cyrus Khandanpour, Tobias Dechow, Holger Hebart, Wolfram Jung, Sebastian Theurich, Georg Maschmeyer, Hans Salwender, Georg Hess, Max Bittrich, Leo Rasche, Annamaria Brioli, Kai-Uwe Eckardt, Christian Straka, Swantje Held, Hermann Einsele & Stefan Knop. (2021) Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM. Cancers 13:6, pages 1322.
Crossref
Angela Dispenzieri & Giampaolo Merlini. (2020) Future Perspectives. Hematology/Oncology Clinics of North America 34:6, pages 1205-1214.
Crossref
Maria Luísa Cordeiro Santos, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Anelise Costa dos Santos Botelho & Fabrício Freire de Melo. (2020) Nephrotoxicity in cancer treatment: An overview. World Journal of Clinical Oncology 11:4, pages 190-204.
Crossref
Rimda Wanchoo, Ala Abudayyeh, Mona Doshi, Amaka Edeani, Ilya G. Glezerman, Divya Monga, Mitchell Rosner & Kenar D. Jhaveri. (2017) Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma. Clinical Journal of the American Society of Nephrology 12:1, pages 176-189.
Crossref
Jolanta Małyszko, Klaudia Kozłowska, Leszek Kozłowski & Jacek Małyszko. (2016) Nephrotoxicity of anticancer treatment. Nephrology Dialysis Transplantation, pages gfw338.
Crossref
Rania Kheder El-Fekih & Hassan Izzedine. (2016) Néphrotoxicité du lénalidomide. Bulletin du Cancer 103:5, pages 499-506.
Crossref
Liliane Hobeika, Sally E Self & Juan Carlos Q Velez. (2014) Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma. BMC Nephrology 15:1.
Crossref
M Rosenzweig, S Giralt & H Landau. (2012) Light-chain amyloidosis: SCT, novel agents and beyond. Bone Marrow Transplantation 48:8, pages 1022-1027.
Crossref
Morie A. Gertz & Robert A. Kyle. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 729 750 .
Éric Moumas, William Hanf, Estelle Desport, Julie Abraham, Sébastien Delbès, Céline Debiais, Laurence Lacotte-Thierry, Guy Touchard, Arnaud Jaccard, Jean-Paul Fermand & Frank Bridoux. (2011) Actualités dans le traitement du myélome avec insuffisance rénale. Néphrologie & Thérapeutique 7:6, pages 457-466.
Crossref
B Wirk. (2011) Renal failure in multiple myeloma: a medical emergency. Bone Marrow Transplantation 46:6, pages 771-783.
Crossref
R. Specter, V. Sanchorawala, D. C. Seldin, A. Shelton, S. Fennessey, K. T. Finn, J. B. Zeldis & L. M. Dember. (2010) Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrology Dialysis Transplantation 26:3, pages 881-886.
Crossref
Surafel Gebreselassie. 2011. Supportive Oncology. Supportive Oncology 44 48 .
Evan J. Lipson, Carol Ann Huff, Danniele G. Holanda, Michael A. McDevitt & Derek M. Fine. (2010) Lenalidomide-Induced Acute Interstitial Nephritis. The Oncologist 15:9, pages 961-964.
Crossref
Laura M. Dember. 2010. Amyloidosis. Amyloidosis 129 143 .
Morie A. Gertz & Francis Buadi. 2010. Amyloidosis. Amyloidosis 155 164 .
Morie A. Gertz & Steven R. Zeldenrust. (2009) Treatment of immunoglobulin light chain amyloidosis. Current Hematologic Malignancy Reports 4:2, pages 91-98.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.